|
1HYI
SOLUTION STRUCTURE OF THE EEA1 FYVE DOMAIN COMPLEXED WITH INOSITOL 1,3-BISPHOSPHATE
Deposited 2001-01-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1346–1410(65 aa)
Fragment:FYVE DOMAIN (RESIDUES 1346-1410)
|
Not recorded
|
ZN ZINC ION × 2
ITP PHOSPHORIC ACID MONO-(2,3,4,6-TETRAHYDROXY-5-PHOSPHONOOXY-CYCLOHEXYL) ESTER × 1
|
SOLUTION NMR
NMR measurement conditions
pH 6.7;298 K;Ionic strength (raw mmCIF value) 200 mM KCl;Pressure 1
NMR sample composition
1mM FYVE domain; 20 mM d-Tris buffer; pH 6.7; 200 mM KCl; 20 mM d-DTT; 1 mM NaN3 | 90% H2O/10% D2O
NMR sample composition
1mM FYVE domain; 20 mM d-Tris buffer; pH 6.7; 200 mM KCl; 20 mM d-DTT; 1 mM NaN3 | 99.99% D2O
|
Resolution not provided
|
|
1HYJ
SOLUTION STRUCTURE OF THE EEA1 FYVE DOMAIN
Deposited 2001-01-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1346–1410(65 aa)
Fragment:FYVE DOMAIN (RESIDUES 1346-1410)
|
Not recorded
|
ZN ZINC ION × 2
|
SOLUTION NMR
NMR measurement conditions
pH 6.7;298 K;Ionic strength (raw mmCIF value) 200 mM KCl;Pressure 1
NMR sample composition
1mM FYVE domain; 20 mM d-Tris buffer; pH 6.7; 200 mM KCl; 20 mM d-DTT; 1 mM NaN3 | 90% H2O/10% D2O
NMR sample composition
1mM FYVE domain; 20 mM d-Tris buffer; pH 6.7; 200 mM KCl; 20 mM d-DTT; 1 mM NaN3 | 99.99% D2O
|
Resolution not provided
|
|
3MJH
Crystal Structure of Human Rab5A in complex with the C2H2 Zinc Finger of EEA1
Deposited 2010-04-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
36–69(34 aa)
Fragment:C2H2-type, residues 36-69
|
Not recorded
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;291 K;18% PEG 4000, 50mM sodium acetate, 0.2M sodium-potassium phosphate, 10% glycerol, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 291.0K
|
Resolution 2.03 Å
R-free 0.260
|
|
3MJH
Crystal Structure of Human Rab5A in complex with the C2H2 Zinc Finger of EEA1
Deposited 2010-04-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
36–69(34 aa)
Fragment:C2H2-type, residues 36-69
|
Not recorded
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5;291 K;18% PEG 4000, 50mM sodium acetate, 0.2M sodium-potassium phosphate, 10% glycerol, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 291.0K
|
Resolution 2.03 Å
R-free 0.260
|